Olivier Dormond

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 14

Top Venues

Cancers

International journal of molecular sciences

Oxidative medicine and cellular longevity

The Journal of cell biology

Lausanne University Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Lausanne University Hospital

Switzerland

Group leader :: Visceral Surgery

Publications

Constantin Gatterer, Dietrich Beiztke, Senta Graf, Max Lenz, Gere Sunder-Plaßmann, Christopher Mann, Markus Ponleitner, Robert Manka, Daniel Fritschi, Pierre-Alexandre Krayenbuehl, Philipp Kamm, Olivier Dormond, Frédéric Barbey, Pierre Monney, Albina Nowak
Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease. Life (Basel, Switzerland) 13 (5) (2023)
Cansaran Saygili Demir, Amélie Sabine, Muyun Gong, Olivier Dormond, Tatiana V Petrova
Mechanosensitive mTORC1 signaling maintains lymphatic valves. The Journal of cell biology 222 (6) (2023)
Benedetta Cena, Emmanuel Melloul, Nicolas Demartines, Olivier Dormond, Ismail Labgaa
Basic Science with Preclinical Models to Investigate and Develop Liquid Biopsy: What Are the Available Data and Is It a Fruitful Approach? International journal of molecular sciences 23 (10) (2022)
Alexandre El Hage, Olivier Dormond
Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment. Cancers 13 (6) (2021)
Magdalena Rausch, Léa Blanc, Olga de Souza Silva, Olivier Dormond, Arjan W Griffioen, Patrycja Nowak-Sliwinska
Characterization of Renal Cell Carcinoma Heterotypic 3D Co-Cultures with Immune Cell Subsets. Cancers 13 (11) (2021)
Ismail Labgaa, Augusto Villanueva, Olivier Dormond, Nicolas Demartines, Emmanuel Melloul
The Role of Liquid Biopsy in Hepatocellular Carcinoma Prognostication. Cancers 13 (4) (2021)
Magdalena Rausch, Adriano Rutz, Pierre-Marie Allard, Céline Delucinge-Vivier, Mylène Docquier, Olivier Dormond, Jean-Luc Wolfender, Patrycja Nowak-Sliwinska
Molecular and Functional Analysis of Sunitinib-Resistance Induction in Human Renal Cell Carcinoma Cells. International journal of molecular sciences 22 (12) (2021)
Magdalena Rausch, Adriano Rutz, Pierre-Marie Allard, Céline Delucinge-Vivier, Mylène Docquier, Olivier Dormond, Paul J Dyson, Jean-Luc Wolfender, Patrycja Nowak-Sliwinska
Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma. Cancers 13 (16) (2021)
Judy R van Beijnum, Andrea Weiss, Robert H Berndsen, Tse J Wong, Louise C Reckman, Sander R Piersma, Marloes Zoetemelk, Richard de Haas, Olivier Dormond, Axel Bex, Alexander A Henneman, Connie R Jimenez, Arjan W Griffioen, Patrycja Nowak-Sliwinska
Integrating Phenotypic Search and Phosphoproteomic Profiling of Active Kinases for Optimization of Drug Mixtures for RCC Treatment. Cancers 12 (9) (2020)
Adrian Paul Duval, Laetitia Troquier, Olga de Souza Silva, Nicolas Demartines, Olivier Dormond
Diclofenac Potentiates Sorafenib-Based Treatments of Hepatocellular Carcinoma by Enhancing Oxidative Stress. Cancers 11 (10) (2019)
Olivier Dormond
mTOR in Human Diseases. International journal of molecular sciences 20 (9) (2019)
Adrian P Duval, Cheryl Jeanneret, Tania Santoro, Olivier Dormond
mTOR and Tumor Cachexia. International journal of molecular sciences 19 (8) (2018)
Seraina Faes, Tania Santoro, Nicolas Demartines, Olivier Dormond
Evolving Significance and Future Relevance of Anti-Angiogenic Activity of mTOR Inhibitors in Cancer Therapy. Cancers 9 (11) (2017)
Seraina Faes, Nicolas Demartines, Olivier Dormond
Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity. Oxidative medicine and cellular longevity 2017 (2017)

Olivier Dormond.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Olivier Dormond